Prevention & Chronic Conditions

Broadcast

Breakthrough Mineralocorticoid Receptor Agonists in Cardiovascular Care

Vijay Chopra, Javed Butler, Dinesh Khullar, et al

Watch time: 1h 4m 2s

About

Cardiovascular disease (CVD) is a significant and ever-growing problem in the UK, accounting for nearly one-third of all deaths and leading to significant morbidity. Globally CVD accounts for 31% of mortality, mainly from heart disease and cerebrovascular accident.

The burden of CVD can be ameliorated by careful risk modification and primary prevention is an important priority for all developers of health policy. Strong consensus exists between international guidelines regarding the necessity of smoking cessation, weight optimisation and exercise, although guidelines have slightly different approaches to hypertension and vary considerably regarding their approach to optimal lipid profile, which remains a contentious issue.

Articles

Introduction to Pulmonary Embolism Treatment: An Evolving Paradigm

Published:

09 September 2025

Citation:

Interventional Cardiology 2025;20:e23.

Case-based Review on Ranolazine for Chronic Coronary Syndrome

Published:

26 August 2025

Citation:

Journal of Asian Pacific Society of Cardiology 2025;4:e26.

EPCs and Innovative Strategies for Endothelial Dysfunction in Heart Failure

Published:

18 August 2025

Citation:

Cardiac Failure Review 2025;11:e21.

Guided or Unguided Antiplatelet Therapy: Clarifying Ambiguity

Published:

14 August 2025

Citation:

Journal of Asian Pacific Society of Cardiology 2025;4:e25.